Medical artificial intelligence (AI) startup Promedius (CEO Bae Hyeon-jin) announced that it will participate in 'WHX Dubai 2026 (Dubai International Medical Equipment Exhibition)' held at the Dubai Exhibition Center from February 9th to 12th.
WHX Dubai 2026 is the largest medical industry exhibition in the Middle East, attracting leading medical device companies and healthcare professionals from around the world. It is a vibrant venue for discussions on business collaborations aimed at expanding into global markets. Promedius plans to use this exhibition to build partnerships in the Middle East and explore local business opportunities.
At this event, Promedius will showcase its osteoporosis screening AI software, "Osteo Signal." Osteo Signal is an AI software that uses chest X-ray images to identify individuals at risk for osteoporosis. Approved by the Ministry of Food and Drug Safety, Osteo Signal can be integrated into existing clinical settings without the need for additional testing or equipment.
The company believes the product has high potential for use in the local healthcare market, as it can be flexibly applied to the clinical and health screening environments of medical institutions in the Middle East.
During the exhibition, Promedius plans to hold numerous business meetings with global medical device companies, as well as medical institutions and distribution partners in the Middle East. Through these meetings, the company aims to concretize discussions on product introduction and collaboration models, and gradually build cooperative relationships in the Middle Eastern market.
Promedius plans to use this exhibition as an opportunity to explore collaboration opportunities with key partners in the Middle East and strengthen its foundation for entering overseas markets.
- See more related articles
You must be logged in to post a comment.